Suchergebnisse - Atreya, Imke

Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis

von Besendorf, Laura, Müller, Tanja M., Geppert, Carol-Immanuel, Schneider, Ines, Mühl, Laura, Atreya, Imke, Vitali, Francesco, Atreya, Raja, Neurath, Markus F., Zundler, Sebastian

Online lesen (frei zugänglich)

Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo

von Fischer, Anika, Zundler, Sebastian, Atreya, Raja, Rath, Timo, Voskens, Caroline, Hirschmann, Simon, López-Posadas, Rocío, Watson, Alastair, Becker, Christoph, Schuler, Gerold, Neufert, Clemens, Atreya, Imke, Neurath, Markus F.

Online lesen (frei zugänglich)

Anti-β7 integrin treatment impedes the recruitment on non‐classical monocytes to the gut and delays macrophage‐mediated intestinal wound healing

von Sommer, Katrin, Heidbreder, Karin, Kreiss, Lucas, Dedden, Mark, Paap, Eva‐Maria, Wiendl, Maximilian, Becker, Emily, Atreya, Raja, Müller, Tanja M., Atreya, Imke, Waldner, Maximilian, Schürmann, Sebastian, Friedrich, Oliver, Neurath, Markus F., Zundler, Sebastian

Online lesen (frei zugänglich)

Nr4a1-dependent non-classical monocytes are important for macrophage-mediated wound healing in the large intestine

von Heidbreder, Karin, Sommer, Katrin, Wiendl, Maximilian, Müller, Tanja M., Atreya, Imke, Hildner, Kai, Neurath, Markus F., Zundler, Sebastian

Online lesen (frei zugänglich)

Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets

von Becker, Emily, Schweda, Anna, Ullrich, Karen A. -M, Voskens, Caroline, Atreya, Raja, Müller, Tanja M., Atreya, Imke, Neurath, Markus F., Zundler, Sebastian

Online lesen (frei zugänglich)

Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study

von Mühl, Laura, Becker, Emily, Müller, Tanja M., Atreya, Raja, Atreya, Imke, Neurath, Markus F., Zundler, Sebastian

Online lesen (frei zugänglich)

Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study

von Allner, Clarissa, Melde, Michaela, Becker, Emily, Fuchs, Friederike, Mühl, Laura, Klenske, Entcho, Müller, Lisa, Morgenstern, Nadine, Fietkau, Konstantin, Hirschmann, Simon, Atreya, Raja, Atreya, Imke, Neurath, Markus F., Zundler, Sebastian

Online lesen (frei zugänglich)

Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease

von Lichnog, Charlotte, Klabunde, Sha, Becker, Emily, Fuh, Franklin, Tripal, Philipp, Atreya, Raja, Klenske, Entcho, Erickson, Rich, Chiu, Henry, Reed, Chae, Chung, Shan, Neufert, Clemens, Atreya, Imke, McBride, Jacqueline, Neurath, Markus F., Zundler, Sebastian

Online lesen (frei zugänglich)

Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles

von Fuchs, Friederike, Schillinger, Daniela, Atreya, Raja, Hirschmann, Simon, Fischer, Sarah, Neufert, Clemens, Atreya, Imke, Neurath, Markus F., Zundler, Sebastian

Online lesen (frei zugänglich)